Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics.
Giving individuals access to their genomic data to improve their healthcare.
We leverage a Sequence Once, Query Often model that allows us to take a single DNA sample, digitize that data and then use it over and over again in the care of that patient to drive beneficial clinical outcomes.
We recently partnered with Gingko Bioworks for pooled COVID testing. We also recently closed our Series C funding for $50m.